Recent advances in early and advanced stage non-small cell lung cancer (NSCLC) presented at ESMO 2023

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site

Oct 24 / Springer Healthcare

Recent advances in early and advanced stage non-small cell lung cancer (NSCLC) presented at ESMO 2023

Oncology Lung Cancer Cancer Immunotherapy ESMO-2023

Description

In this engaging panel discussion, renowned experts in non-small cell lung cancer, Dr Paz-Ares, Prof Peters and Dr Garassino, discuss the latest findings from the pivotal phase III ALINA, CheckMate-77T, LIBRETTO-431, and MARIPOSA-1 and -2 trials presented at ESMO 2023.

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.